Liferay Portal/DXP Membership Page Name cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, has been found in Liferay Portal and DXP. This affects an unknown part of the component Membership Page. The manipulation of the argument Name leads to cross site scripting. This vulnerability is listed as CVE-2025-62238. The attack may be initiated remotely. There is no available exploit.
Details
A vulnerability was found in Liferay Portal and DXP (affected version unknown). It has been rated as problematic. This issue affects an unknown functionality of the component Membership Page. The manipulation of the argument Name with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Stored cross-site scripting (XSS) vulnerability on the Membership page in Account Settings in Liferay Portal 7.4.3.21 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.5, 2023.Q3.1 through 2023.Q3.8, and 7.4 update 21 through update 92 allows remote authenticated attackers to inject arbitrary web script or HTML via a crafted payload injected into a Account's “Name“ text field.
It is possible to read the advisory at liferay.dev. The identification of this vulnerability is CVE-2025-62238 since 10/09/2025. The exploitation is known to be easy. The attack may be initiated remotely. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-33720). Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Type
Vendor
Name
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
10/09/2025 CVE reserved10/10/2025 Advisory disclosed
10/10/2025 VulDB entry created
12/13/2025 VulDB entry last update
Sources
Advisory: liferay.devStatus: Confirmed
CVE: CVE-2025-62238 (🔒)
GCVE (CVE): GCVE-0-2025-62238
GCVE (VulDB): GCVE-100-327923
EUVD: 🔒
Entry
Created: 10/10/2025 15:00Updated: 12/13/2025 11:00
Changes: 10/10/2025 15:00 (66), 10/11/2025 06:07 (1), 12/13/2025 11:00 (11)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.